{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:06:27Z","timestamp":1791486387084,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-026-01603-1","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:52:02Z","timestamp":1791438722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tegoprazan regulates gut microbiota structure in Helicobacter pylori-induced ulcerative colitis mice"],"prefix":"10.1007","author":[{"given":"Aijie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"e057214","DOI":"10.1136\/bmjopen-2021-057214","volume":"3","author":"EW Abd El-Wahab","year":"2022","unstructured":"Abd El-Wahab EW, Youssef EI, Hassouna E (2022) Helicobacter pylori infection in patients with inflammatory bowel diseases: a single-centre, prospective, observational study in Egypt. BMJ Open May 3:12:e057214 Epub 2022\/05\/04","journal-title":"BMJ Open May"},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"e1007866","DOI":"10.1371\/journal.ppat.1007866","volume":"15","author":"IC Arnold","year":"2019","unstructured":"Arnold IC, Zhang X, Artola-Boran M, Fallegger A, Sander P, Johansen P, Muller A (2019) BATF3-dependent dendritic cells drive both effector and regulatory T-cell responses in bacterially infected tissues. PLoS Pathog Jun 15:e1007866 Epub 2019\/06\/13","journal-title":"PLoS Pathog Jun"},{"key":"1603_CR3","first-page":"1","volume":"13","author":"CC Chen","year":"2021","unstructured":"Chen CC, Liou JM, Lee YC, Hong TC, El-Omar EM, Wu MS (2021) The interplay between Helicobacter pylori and gastrointestinal microbiota. Gut Microbes Jan\u2013Dec 13:1\u201322 Epub 2021\/05\/04","journal-title":"Gut Microbes Jan\u2013Dec"},{"key":"1603_CR5","first-page":"1","volume":"3","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liu Y, Wang Y, Chen X, Wang C, Chen X, Yuan X, Liu L, Yang J, Zhou X (2022) Prevotellaceae produces butyrate to alleviate PD-1\/PD-L1 inhibitor-related cardiotoxicity via PPARalpha-CYP4X1 axis in colonic macrophages. J Exp Clin Cancer Res Jan 3:41:1 Epub 2022\/01\/05","journal-title":"J Exp Clin Cancer Res Jan"},{"key":"1603_CR4","doi-asserted-by":"publisher","first-page":"166984","DOI":"10.1016\/j.bbadis.2023.166984","volume":"1870","author":"H Chen","year":"2024","unstructured":"Chen H, Qian Y, Jiang C, Tang L, Yu J, Zhang L, Dai Y, Jiang G (2024) Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2\/GPX4 signal pathway and improving intestinal barrier. Biochim Biophys Acta Mol Basis Dis Feb 1870:166984 Epub 2023\/12\/08","journal-title":"Biochim Biophys Acta Mol Basis Dis Feb"},{"key":"1603_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/apt.15865","volume":"52","author":"YK Cho","year":"2020","unstructured":"Cho YK, Choi MG, Choi SC, Lee KM, Kim TO, Park SH, Moon JS, Lim YJ, Kang DH, Cheon GJ et al (2020) Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer. Aliment Pharmacol Ther Sep 52:789\u2013797 Epub 2020\/07\/24","journal-title":"Aliment Pharmacol Ther Sep"},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.cmet.2021.10.010","volume":"2","author":"D Erny","year":"2021","unstructured":"Erny D, Dokalis N, Mezo C, Castoldi A, Mossad O, Staszewski O, Frosch M, Villa M, Fuchs V, Mayer A et al (2021) Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab Nov 2:33:2260\u20132276 e2267. Epub 2021\/11\/04","journal-title":"Cell Metab Nov"},{"key":"1603_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2022.04.006","volume":"1055","author":"SF Erttmann","year":"2022","unstructured":"Erttmann SF, Swacha P, Aung KM, Brindefalk B, Jiang H, Hartlova A, Uhlin BE, Wai SN, Gekara NO (2022) The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immun May 1055:847\u2013861 e810. Epub 2022\/05\/12","journal-title":"Immun May"},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.3748\/wjg.v25.i41.6222","volume":"7","author":"J Feng","year":"2019","unstructured":"Feng J, Guo J, Wang JP, Chai BF (2019) MiR-32-5p aggravates intestinal epithelial cell injury in pediatric enteritis induced by Helicobacter pylori. World J Gastroenterol Nov 7:25:6222\u20136237 Epub 2019\/11\/22","journal-title":"World J Gastroenterol Nov"},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX (2017) The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterol Mar 152:706\u2013715 Epub 2017\/03\/05","journal-title":"Gastroenterol Mar"},{"key":"1603_CR11","first-page":"118","volume":"46","author":"W Fu","year":"2025","unstructured":"Fu W, Huang Z, Li W, Xu L, Yang M, Ma Y, Liu H, Qian H, Wang W (2025) Copper-luteolin nanocomplexes for Mediating multifaceted regulation of oxidative stress, intestinal barrier, and gut microbiota in inflammatory bowel disease. Bioact Mater Apr 46:118\u2013133 Epub 2025\/01\/06","journal-title":"Bioact Mater Apr"},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/gutjnl-2024-332640","volume":"8","author":"W Gao","year":"2024","unstructured":"Gao W, Liu J, Wang X, Li J, Zhang X, Ye H, Li J, Dong X, Liu B, Wang C et al (2024) Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy. Gut Aug 8:73:1414\u20131420 Epub 2024\/06\/22","journal-title":"Gut Aug"},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3389\/fphar.2019.00852","volume":"10","author":"P Irun","year":"2019","unstructured":"Irun P, Lanas A, Piazuelo E (2019) Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review. Front Pharmacol 10:852 Epub 2019\/08\/21","journal-title":"Front Pharmacol"},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"e2417050","DOI":"10.1002\/adma.202417050","volume":"37","author":"J Jiang","year":"2025","unstructured":"Jiang J, Ma Y, Zhou L, Han W, Liang Y, Dong J, Ding Y, Li W, Lei Q, Li J et al (2025) Synergistic Genetic and Chemical Engineering of Probiotics for Enhanced Intestinal Microbiota Regulation and Ulcerative Colitis Treatment. Adv Mater Jul 37:e2417050 Epub 2025\/06\/02","journal-title":"Adv Mater Jul"},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1002\/jsfa.14374","volume":"105","author":"V Kaliyamoorthy","year":"2025","unstructured":"Kaliyamoorthy V, Jacop JP, Ibrahim HIM, Kandhasamy S (2025) Lactobacillus plantarum with lignin prevents Helicobacter pylori mediated DSS-colitis through improved intestinal integrity and reducing colonic inflammation in C57BL\/6J mice. J Sci Food Agric Sep 105:6330\u20136340 Epub 2025\/05\/21","journal-title":"J Sci Food Agric Sep"},{"key":"1603_CR16","doi-asserted-by":"crossref","unstructured":"Kang SH, Moon HS, Sung JK, Kim SM, Kim KB, Lee SW, Cho YS, Bang KB, Song KH (2025) Assessment of the efficacy of on-demand tegoprazan therapy in gastroesophageal reflux disease through a randomized controlled trial. Sci Rep. Jan 2;15:168. Epub 2025\/01\/03","DOI":"10.1038\/s41598-024-84065-0"},{"key":"1603_CR17","doi-asserted-by":"publisher","first-page":"1015890","DOI":"10.3389\/fcimb.2022.1015890","volume":"12","author":"B Khorsand","year":"2022","unstructured":"Khorsand B, Asadzadeh Aghdaei H, Nazemalhosseini-Mojarad E, Nadalian B, Nadalian B, Houri H (2022) Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn\u2019s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets. Front Cell Infect Microbiol 12:1015890 Epub 2022\/10\/22","journal-title":"Front Cell Infect Microbiol"},{"key":"1603_CR18","doi-asserted-by":"crossref","unstructured":"Kong Q, Mirza IA, Zhang X, Song X, Li X, Zhang Q, Xu L, Guo Y, Yu Y, Zuo X et al (2024) Fourteen-Day Tegoprazan-Amoxicillin Dual Therapy as the First-Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial. Helicobacter. May\u2013Jun;29:e13098. Epub 2024\/06\/10.","DOI":"10.1111\/hel.13098"},{"key":"1603_CR19","first-page":"1","volume":"9","author":"PV Kuprys","year":"2020","unstructured":"Kuprys PV, Cannon AR, Shieh J, Iftekhar N, Park SK, Eberhardt JM, Ding X, Choudhry MA (2020) Alcohol decreases intestinal ratio of Lactobacillus to Enterobacteriaceae and induces hepatic immune tolerance in a murine model of DSS-colitis. Gut Microbes Nov 9:12:1\u201316 Epub 2020\/11\/13","journal-title":"Gut Microbes Nov"},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ame2.12456","volume":"7","author":"ME Lange","year":"2024","unstructured":"Lange ME, Bescucci DM, Boras VF, Montina T, Inglis GD (2024) Assessment of the piroxicam-incited model of synchronized colitis in T-cell receptor alpha chain-deficient mice. Anim Model Exp Med Aug 7:533\u2013543 Epub 2024\/07\/12","journal-title":"Anim Model Exp Med Aug"},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"27173","DOI":"10.1038\/s41598-024-78581-2","volume":"8","author":"HJ Lee","year":"2024","unstructured":"Lee HJ, Moon JW, Koh SJ, Im JP, Kim BG, Kim JS (2024) Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy. Sci Rep Nov 8:14:27173 Epub 2024\/11\/13","journal-title":"Sci Rep Nov"},{"key":"1603_CR22","doi-asserted-by":"publisher","first-page":"e2413128","DOI":"10.1002\/advs.202413128","volume":"12","author":"J Lei","year":"2025","unstructured":"Lei J, Lv L, Zhong L, Xu F, Su W, Chen Y, Wu Z, He S, Chen Y (2025) The Gut Microbiota Affects Anti-TNF Responsiveness by Activating the NAD(+) Salvage Pathway in Ulcerative Colitis. Adv Sci (Weinh) Feb 12:e2413128 Epub 2025\/01\/01","journal-title":"Adv Sci (Weinh) Feb"},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"106368","DOI":"10.1016\/j.phrs.2022.106368","volume":"183","author":"X Li","year":"2022","unstructured":"Li X, Li Q, Xiong B, Chen H, Wang X, Zhang D (2022) Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis. Pharmacol Res Sep 183:106368 Epub 2022\/07\/30","journal-title":"Pharmacol Res Sep"},{"key":"1603_CR24","doi-asserted-by":"publisher","first-page":"2377576","DOI":"10.1080\/19490976.2024.2377576","volume":"16","author":"M Li","year":"2024","unstructured":"Li M, Ding Y, Wei J, Dong Y, Wang J, Dai X, Yan J, Chu F, Zhang K, Meng F et al (2024) Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation. Gut Microbes Jan\u2013Dec 16:2377576 Epub 2024\/07\/28","journal-title":"Gut Microbes Jan\u2013Dec"},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"eadm6843","DOI":"10.1126\/sciimmunol.adm6843","volume":"18","author":"B Li","year":"2025","unstructured":"Li B, Sakaguchi T, Tani H, Ito T, Murakami M, Okumura R, Kobayashi M, Okuzaki D, Motooka D, Ikeuchi H et al (2025) OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation. Sci Immunol Jul 18:10:eadm6843 Epub 2025\/07\/18","journal-title":"Sci Immunol Jul"},{"key":"1603_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","volume":"157","author":"P Moayyedi","year":"2019","unstructured":"Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Stork S, Branch KRH et al (2019) Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterol Sep 157:682\u2013691 e682. Epub 2019\/06\/04","journal-title":"Gastroenterol Sep"},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.chom.2023.01.006","volume":"8","author":"M Naama","year":"2023","unstructured":"Naama M, Telpaz S, Awad A, Ben-Simon S, Harshuk-Shabso S, Modilevsky S, Rubin E, Sawaed J, Zelik L, Zigdon M et al (2023) Autophagy controls mucus secretion from intestinal goblet cells by alleviating ER stress. Cell Host Microbe Mar 8:31:433\u2013446 e434. Epub 20230203","journal-title":"Cell Host Microbe Mar"},{"key":"1603_CR28","first-page":"15","volume":"10","author":"L Olmedo","year":"2024","unstructured":"Olmedo L, Calvet X, Gene E, Bordin DS, Voynovan I, Castro-Fernandez M, Pabon-Carrasco M, Keco-Huerga A, Perez-Aisa A, Lucendo AJ et al (2024) Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg). Gut Dec 10:74:15\u201325 Epub 2024\/10\/27","journal-title":"Gut Dec"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","volume":"30","author":"KF Pan","year":"2024","unstructured":"Pan KF, Li WQ, Zhang L, Liu WD, Ma JL, Zhang Y, Ulm K, Wang JX, Zhang L, Bajbouj M et al (2024) Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. Nat Med Nov 30:3250\u20133260 Epub 2024\/07\/31","journal-title":"Nat Med Nov"},{"key":"1603_CR30","first-page":"e70106","volume":"31","author":"JY Park","year":"2026","unstructured":"Park JY, Hong SJ, Choi IJ, Baik GH, Kim SM, Park JJ, Jeon SW, Kim KO, Lee SK, Jung HY et al (2026) Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial. Helicobacter. Jan\u2013Feb 31:e70106","journal-title":"Jan\u2013Feb"},{"key":"1603_CR31","first-page":"e13117","volume":"29","author":"C Peng","year":"2024","unstructured":"Peng C, Xu X, Ouyang Y, Li Y, Lu N, Zhu Y, He C (2024) Spatial Variation of the Gastrointestinal Microbiota in Response to Long-Term Administration of Vonoprazan in Mice With High Risk of Gastric Cancer. Helicobacter. Jul\u2013Aug 29:e13117 Epub 2024\/08\/01","journal-title":"Jul\u2013Aug"},{"key":"1603_CR32","doi-asserted-by":"publisher","first-page":"108831","DOI":"10.1016\/j.pharmthera.2025.108831","volume":"269","author":"G Petracco","year":"2025","unstructured":"Petracco G, Faimann I, Reichmann F (2025) Inflammatory bowel disease and neuropsychiatric disorders: Mechanisms and emerging therapeutics targeting the microbiota-gut-brain axis. Pharmacol Ther May 269:108831 Epub 2025\/03\/03","journal-title":"Pharmacol Ther May"},{"key":"1603_CR33","doi-asserted-by":"publisher","first-page":"123387","DOI":"10.1016\/j.carbpol.2025.123387","volume":"15","author":"JY Shi","year":"2025","unstructured":"Shi JY, Wang YJ, Bao QW, Qin YM, Li PP, Wu QQ, Xia CK, Wu DL, Xie SZ (2025a) Polygonatum cyrtonema Hua polysaccharide alleviates ulcerative colitis via gut microbiota-independent modulation of inflammatory immune response. Carbohydr Polym May 15:356:123387 Epub 2025\/03\/07","journal-title":"Carbohydr Polym May"},{"key":"1603_CR34","doi-asserted-by":"publisher","first-page":"e05921","DOI":"10.1002\/advs.202505921","volume":"12","author":"R Shi","year":"2025","unstructured":"Shi R, Tan W, Jin H, Chan SI, Li W, Lei SS, Cui G, Wang Y, Yang DH, Zhong Z (2025b) MicroRNA-Enriched Plant-Derived Exosomes Alleviate Colitis by Modulating Systemic Immunity, Metabolic Homeostasis, and Gut Microbiota. Adv Sci (Weinh) Nov 12:e05921 Epub 2025\/09\/25","journal-title":"Adv Sci (Weinh) Nov"},{"key":"1603_CR35","doi-asserted-by":"publisher","unstructured":"Singh S, Loftus EV Jr, Limketkai BN, Haydek JP, Agrawal M, Scott FI, Ananthakrishnan AN (2024) AGA living clinical practice guideline on pharmacological management of moderate-to-severe ulcerative colitis. Gastroenterology 167:1307\u20131343. https:\/\/doi.org\/10.1053\/j.gastro.2024.10.001","DOI":"10.1053\/j.gastro.2024.10.001"},{"key":"1603_CR36","doi-asserted-by":"publisher","first-page":"870817","DOI":"10.3389\/fimmu.2022.870817","volume":"13","author":"M Son","year":"2022","unstructured":"Son M, Park IS, Kim S, Ma HW, Kim JH, Kim TI, Kim WH, Han J, Kim SW, Cheon JH (2022) Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function. Front Immunol 13:870817 Epub 2022\/06\/14","journal-title":"Front Immunol"},{"key":"1603_CR37","doi-asserted-by":"publisher","first-page":"e2412551","DOI":"10.1002\/advs.202412551","volume":"12","author":"R Sun","year":"2025","unstructured":"Sun R, Zhang Y, Zhao X, Tang T, Cao Y, Yang L, Tian Y, Zhang Z, Zhang P, Xu F (2025) Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis-Associated Colorectal Cancer. Adv Sci (Weinh) Mar 12:e2412551 Epub 2025\/01\/22","journal-title":"Adv Sci (Weinh) Mar"},{"key":"1603_CR38","doi-asserted-by":"publisher","first-page":"e21004","DOI":"10.1016\/j.heliyon.2023.e21004","volume":"9","author":"W Tang","year":"2023","unstructured":"Tang W, Guan M, Li Z, Pan W, Wang Z (2023) A2BR facilitates the pathogenesis of H. pylori-associated GU by inducing oxidative stress through p38 MAPK phosphorylation. Heliyon Nov 9:e21004 Epub 20231020","journal-title":"Heliyon Nov"},{"key":"1603_CR39","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk P, Yeshi K, Loukas A (2024) Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci Oct 45:892\u2013903 Epub 2024\/09\/12","journal-title":"Trends Pharmacol Sci Oct"},{"key":"1603_CR40","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1136\/gutjnl-2011-301439","volume":"62","author":"CS Williams","year":"2013","unstructured":"Williams CS, Bradley AM, Chaturvedi R, Singh K, Piazuelo MB, Chen X, McDonough EM, Schwartz DA, Brown CT, Allaman MM et al (2013) MTG16 contributes to colonic epithelial integrity in experimental colitis. Gut Oct 62:1446\u20131455 Epub 2012\/07\/27","journal-title":"Gut Oct"},{"key":"1603_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40168-021-01115-9","volume":"7","author":"Z Wu","year":"2021","unstructured":"Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S et al (2021) Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome Sep 7:9:184 Epub 2021\/09\/09","journal-title":"Microbiome Sep"},{"key":"1603_CR43","doi-asserted-by":"publisher","first-page":"2292254","DOI":"10.1080\/19490976.2023.2292254","volume":"16","author":"X Wu","year":"2024","unstructured":"Wu X, Zhang T, Zhang T, Park S (2024) The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning. Gut Microbes Jan\u2013Dec 16:2292254 Epub 2023\/12\/20","journal-title":"Gut Microbes Jan\u2013Dec"},{"key":"1603_CR41","doi-asserted-by":"publisher","first-page":"103746","DOI":"10.1016\/j.redox.2025.103746","volume":"85","author":"H Wu","year":"2025","unstructured":"Wu H, Li YL, Wang Y, Wang YG, Hong JH, Pang MM, Liu PM, Yang JJ (2025a) Anemoside B4 alleviates ulcerative colitis by attenuating intestinal oxidative stress and NLRP3 inflammasome via activating aryl hydrocarbon receptor through remodeling the gut microbiome and metabolites. Redox Biol Sep 85:103746 Epub 2025\/07\/03","journal-title":"Redox Biol Sep"},{"key":"1603_CR42","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1053\/j.gastro.2025.03.039","volume":"169","author":"X Wu","year":"2025","unstructured":"Wu X, Li Y, Li P, Lu G, Wu J, Wang Z, Wen Q, Cui B, Wang J, Zhang F (2025b) Structural Variations in Ulcerative Colitis-associated Escherichia coli Reduce Fructose Utilization and Aggravate Inflammation Under High-Fructose Diet. Gastroenterol Oct 169:909\u2013924 Epub 2025\/04\/19","journal-title":"Gastroenterol Oct"},{"key":"1603_CR45","doi-asserted-by":"publisher","first-page":"1119037","DOI":"10.3389\/fcimb.2023.1119037","volume":"13","author":"P Xue","year":"2023","unstructured":"Xue P, Sang R, Li N, Du S, Kong X, Tai M, Jiang Z, Chen Y (2023) A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota. Front Cell Infect Microbiol 13:1119037 Epub 2023\/04\/24","journal-title":"Front Cell Infect Microbiol"},{"key":"1603_CR46","first-page":"2158","volume":"156","author":"X Yao","year":"2019","unstructured":"Yao X, Smolka AJ (2019) Gastric Parietal Cell Physiology and Helicobacter pylori-Induced Disease. Gastroenterol Jun 156:2158\u20132173 Epub 2019\/03\/05","journal-title":"Gastroenterol Jun"},{"key":"1603_CR48","doi-asserted-by":"publisher","first-page":"21116","DOI":"10.1021\/acsnano.3c04819","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Yuan Z, Wu J, He Y, Lu G, Zhang D, Zhao Y, Wu R, Lv Y, Cai K et al (2023) An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis. ACS Nano Nov 14:17:21116\u201321133 Epub 2023\/10\/16","journal-title":"ACS Nano Nov"},{"key":"1603_CR47","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1007\/s00210-025-03787-8","volume":"398","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang J, Xu Y, Wei K, Lin W, Hu H, Liu Y (2025a) Akkermansia muciniphila relieves inflammatory response in DSS-induced ulcerative colitis in mice through regulating macrophage polarization via SCFAs-SLC52A2\/FFAR2 pathway. Naunyn Schmiedebergs Arch Pharmacol Jul 398:8695\u20138711 Epub 2025\/01\/22","journal-title":"Naunyn Schmiedebergs Arch Pharmacol Jul"},{"key":"1603_CR49","doi-asserted-by":"crossref","unstructured":"Zhang Y, Ji W, Qin H, Chen Z, Zhou Y, Zhou Z, Wang J, Wang K (2025b) Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17\/Treg cell homeostasis in a microbiota-dependent manner. Carbohydr Polym. Feb 1;349:122829. Epub 2024\/12\/07","DOI":"10.1016\/j.carbpol.2024.122829"},{"key":"1603_CR50","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41591-024-03280-4","volume":"30","author":"J Zheng","year":"2024","unstructured":"Zheng J, Sun Q, Zhang M, Liu C, Su Q, Zhang L, Xu Z, Lu W, Ching J, Tang W et al (2024) Noninvasive, microbiome-based diagnosis of inflammatory bowel disease. Nat Med Dec 30:3555\u20133567 Epub 2024\/10\/05","journal-title":"Nat Med Dec"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01603-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01603-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01603-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:02:44Z","timestamp":1791482564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-026-01603-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":50,"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01603-1","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"1 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Experimental Animal Care Board of 970 Hospital of the Joint Logistics Support Force of the PLA (No. 20251201), and strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals. All procedures were performed in accordance with ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they have no conflicts of interest regarding this work.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}